FIELD: medicine.
SUBSTANCE: method involves delivering drugs directly to optic nerve via infusion system placed in retrobulbar space. 4 mg of Dexamethason in 1 ml of solution is introduced beginning from 8 o'clock in the morning every 30 min. The first three days, it takes place 5 times at daily dose of 20 mg. Daily dose of 16 mg is given four times at the fourth and fifth day. Daily dose of 12 mg is administered three times at the sixth and seventh day. Daily dose of 8 mg is given twice at the eighth and ninth day. Daily dose of 4 mg is given once at the tenth day. Trental, Emoxipin, Solcoseryl and Taufon are delivered to the optic nerve afternoons at a dose of 0.5 ml each, beginning from 12 o'clock with 2 h long pause via infusion system.
EFFECT: accelerated treatment course; reduced risk of traumatic complications.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR COMPLEX TREATMENT OF INFECTIOUS ACUTE OPTICAL NEURITIS | 2016 |
|
RU2623870C1 |
| METHOD FOR DEVELOPING A DEPOT OF MEDICINAL SUBSTANCES IN THE FIELD OF OPHTHALMOLOGY | 2004 |
|
RU2268689C1 |
| METHOD OF OPTICAL NEURITIS TREATMENT | 2009 |
|
RU2414900C1 |
| METHOD OF TREATING DOG'S CORNEAL, RETINAL AND OPTIC NERVE DISEASES | 2011 |
|
RU2481112C1 |
| METHOD FOR TREATING OCULAR ISCHEMIC DISEASES | 2002 |
|
RU2229863C2 |
| METHOD OF TREATING MONOCULAR OPTIC NEURITIS ACCOMPANYING MULTIPLE SCLEROSIS | 2013 |
|
RU2523146C1 |
| METHOD FOR TREATMENT OF SEVERE FORM OF ACUTE OPTICAL NEURITIS IN PATIENT WITH CEREBROSPINAL SCLEROSIS | 2004 |
|
RU2261713C1 |
| METHOD OF COMBINED CONSERVATIVE TREATMENT OF ACTIVE ENDOCRINE OPHTHALMOPATHY | 2022 |
|
RU2806503C1 |
| METHOD OF TREATING PATIENTS WITH CRANIOCEREBRAL INJURY | 2012 |
|
RU2498826C1 |
| METHOD FOR TREATING RETINAL DYSTROPHY AND PARTIAL OPTIC NERVE ATROPHY CASES | 2006 |
|
RU2306946C1 |
